-
Saint-Gobain Completes Second of Seven Manufacturing Expansions
contractpharma
December 03, 2019
With construction just ending on its new facility in Largo, FL, Saint-Gobain Life Sciences has achieved another milestone of its €70 million global expansion program ...
-
Vetter’s Chicago Site Wins Award
contractpharma
September 23, 2019
Winning companies recognized for making better business, creating richer lives and building a stronger community as a whole.
-
Sharp’s Netherlands Facility Approved for Clinical Operations
contractpharma
September 16, 2019
Sharp, part of UDG Healthcare plc, a global provider of contract packaging and clinical supply services, has received Wholesale Distribution Authorization (WDA) and Investigational Medicinal Product (IMP) ...
-
Shimadzu Opens New Mid-Atlantic Facility
contractpharma
September 09, 2019
Expands laboratory services for regional customers.
-
Catalent Invests $9M in New Clinical Supply Facility
contractpharma
September 06, 2019
New 24,257 sq.-ft. facility in San Diego will specialize in services for early-phase clinical trials.
-
BiomX Completes In-house Phage Manufacturing Facility
contractpharma
September 04, 2019
BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, has completed construction of a new state-of-the-art manufacturing facility.
-
Pfizer invests half billion dollars to advance state-of-the-art gene therapy facility in Sanford, North Carolina
worldpharmanews
September 02, 2019
Pfizer announced an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford...
-
Pfizer Invests $500M in Gene Therapy Facility
contractpharma
August 22, 2019
The Sanford, NC site to support continuing investment in gene therapy R&D .
-
HALIX Starts Operational Production with New cGMP Facility in Q4-2019
b3cnewswire
August 13, 2019
HALIX, a contract development and manufacturing organization of clinical and commercial proteins and viral products, based in the Netherlands...
-
US FDA completes audit of Dr Reddy’s Louisiana-based facility
expresspharma
August 12, 2019
Dr Reddy’s Laboratories announced the US health regulator has completed audit of its Louisiana-based formulations manufacturing facility, following which no form 483 was issued.